RELEASES
-
For further information contact:
Fred Iannotti
802-888-0085
fiannotti@planningsource.comOral Cancer: The Shadow Behind Your Smile
Rejuvenation Dentistry's Dr. Curatola Blogs at FoxNews.com About Trimira's Identafi 3000 ultra Oral Cancer Detection Device
NEW YORK CITY, April 15, 2010 — One American dies every hour of every day from "the shadow behind your smile" — oral cancer — according to dentist Dr. Gerald P. Curatola, an NYU professor, speaker, author, and expert in rejuvenation dentistry.
FOX NEWS Health Blog
http://health.blogs.foxnews.com/2010/04/08/oral-cancer-the-shadow-behind-your-smile/Dr. Curatola, who appears on The Dr. Oz Show on April 19 to demonstrate Houston-based Trimira® LLC's Identafi® 3000 ultra dental device on a member of the TV studio audience, said in his April 8th FOXNews.com health blog that oral cancer has become one of the most deadly cancers. More than 35,000 Americans will be diagnosed with oral or pharyngeal cancer this year. Only a bit over half will be alive in five years.
Identafi® 3000 ultra is the world's most advanced oral cancer detection device.
The oral cancer number is one that has not significantly improved in decades. In fact, this is the fourth year in a row in which there has been an increase in the rate of occurrence of oral cancers. Indeed, in 2007, the rate spiked by 11 percent.
Noting the recent change in the oral cancer demographic from the traditional one of smokers and drinkers, Curatola said "a new cause has shifted the focus to much younger people with no other risk factors." He said: "Exposure to HPV-16 and HPV-18 virus (human papiloma virus) transmitted by oral sex has become a major concern."
HPV-16 and -18 are the same viruses responsible for a majority of cervical cancers.
Curatola called oral cancer "the cancer you can catch."
Citing the five times increase in the occurrence of oral cancer in those under the age of 40, Curatola observed that annual oral cancer screenings are recommended for all patients over the age of 17. Early screening boosts the survival rate to 90 percent.
Among the good news that Curatola cited are "technological advances in devices for the early detection of oral cancer." New technology makes it easier to find abnormalities, and precancerous and cancerous lesions before they are observable to the naked eye.
He described Identafi® 3000 ultra as featuring "a multispectral technology using three different light wavelengths." Identafi® 3000 ultra is, he said, "highly portable, hand-held battery-operated instrument that emits a powerful while, violet, and green/amber light that excites the oral tissues in distinct ways to uncover...a deadly lesion lurking in the mouth."
Curatola noted that many dentists "are still not using the assistance of an early detection device, whilch improves the patient's survival rate dramatically."
About Dr. Gerald P. Curatola
Dr. Gerald P. Curatola is a renowned aesthetic dentist and pioneer in the emerging field of rejuvenation dentistry, which improves patients’ overall health and appearance by integrating total wellness with cutting edge oral care and restorative procedures. In addition to his private practice, research, and work as a clinical associate professor at the New York University College of Dentistry, he is an internationally sought after speaker, author, and expert who has been featured widely in print and broadcast media. For more information, visit www.rejuvenationdentistry.com.
About Trimira LLC
Trimira® LLC is a private capital-funded company, with investment by Dallas cancer research philanthropist T. Boone Pickens, of oil and windfarming fame. Other Trimira® sister subsidiaries are working on screening and diagnostic devices for skin, cervical, gastrointestinal, and bladder cancers. Remicalm®, as the parent company, has licensed exclusive use of certain of its patents and patents pending for use as a cervical cancer product to be later expanded to include additional epithelial-based cancers. Remicalm®'s core technologies are based on high-speed, high-resolution capabilities from its patented optical processing technology platforms and include the ability to read metabolic and physiologic differences in diseased and healthy tissue in the human body.
Visit Trimira® at: http://www.trimira.net/
Animations
Identafi® Technology
Identafi® 3000 ultra Process
Screening Results
Training
